Korro Bio

Biotechnology Research • Cambridge, Massachusetts, United States • 51-100 Employees

Company overview

Headquarters	One Kendall Square, Building 600-700, Suite 6-401, Cambridge, Massachusetts 02139, US
Phone number	+18572012700
Website	korrobio.com
NAICS	541714
SIC	873
Employees	51-100
Socials

Key Contacts at Korro Bio

Brian Denehy

Director, Talent Acquisition

Maryam Habibian

Director, Head Of Medicinal Chemistry

Diane Ramsden

Senior Director

Robert Mack

Director Facilities & Laboratory Operations

Shanhu Hu

Director, Platform Biology

Peter Aquino

Executive Director

Christopher J. Stull

Senior Director, Contracts Counsel

Tim Pearson

Member Board Of Directors

David Ulkoski

Director

Christian Roy

Director, Data Sciences

Korro Bio Email Formats

Korro Bio uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@korrobio.com), used 52.4% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@korrobio.com	52.4%
{first initial}{last name}	jdoe@korrobio.com	46.4%
{last name}{last name}	doedoe@korrobio.com	1.2%

About Korro Bio

Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body’s natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function, addressing the medical needs of patients. Our mission is to rewrite the future for patients living with debilitating disease by repairing the underlying genetic cause.

Korro Bio revenue & valuation

Annual revenue	$6,281,000
Revenue per employee	$63,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$20,100,000
Total funding	$186,000,000